Accessibility Statement

Press Releases


Lilly to Participate in Cowen's 44th Annual Health Care Conference

February 20, 2024

Tags |  Financial

INDIANAPOLIS , Feb. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Cowen's 44th Annual Health Care Conference on March 6, 2024 . Anat Ashkenazi, executive vice president and chief financial officer, will take part in a fireside chat at 9:10 a.m., Eastern time .




Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance

February 6, 2024

Tags |  Financial

Revenue in Q4 2023 increased 28%. New Products (i) revenue grew by $2.19 billion to $2.49 billion in Q4 2023, led by Mounjaro and Zepbound. Growth Products (ii) revenue increased 9% to $5.27 billion in Q4 2023, led by Verzenio and Jardiance. Pipeline progress included  FDA approval of Zepbound for




Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance

January 23, 2024

Tags |  Financial

INDIANAPOLIS , Jan. 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2023 financial results and 2024 financial guidance on Feb. 6, 2024 . Lilly will also conduct a conference call that day with the investment community and media to further detail the




Lilly to Participate in J.P. Morgan Healthcare Conference

January 2, 2024

Tags |  Financial

INDIANAPOLIS , Jan. 2, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the 42nd Annual J.P. Morgan Healthcare Conference , Jan. 8-11, 2024 . David A. Ricks, Lilly 's chair and CEO, will participate in a fireside chat on Jan. 9 at 5:15 p.m. Eastern time .




Lilly Announces 15% Dividend Increase, First-Quarter 2024 Dividend

December 8, 2023

Tags |  Financial

INDIANAPOLIS , Dec. 8, 2023 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has announced a 15% increase in its quarterly dividend and declared a dividend for the first quarter of 2024 of $1.30 per share on outstanding common stock.




Lilly to Participate in Evercore ISI HealthCONx Conference

November 14, 2023

Tags |  Financial

INDIANAPOLIS , Nov. 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the sixth annual Evercore ISI HealthCONx Conference on Nov. 28, 2023 . Daniel Skovronsky, M.D., Ph.D., executive vice president, chief scientific and medical officer, and president of Lilly Research




Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity

November 2, 2023

Tags |  Financial

Revenue in Q3 2023 increased 37%, driven by growth from Mounjaro, Verzenio and Jardiance, as well as $1.42 billion from the sale of rights for the olanzapine portfolio (Zyprexa). Excluding revenue from the olanzapine portfolio and COVID-19 antibodies, revenue in Q3 2023 increased 24%.




Lilly Declares Fourth-Quarter 2023 Dividend

November 1, 2023

Tags |  Financial

INDIANAPOLIS , Nov. 1, 2023 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2023 of $1.13 per share on outstanding common stock. The dividend is payable on Dec. 8, 2023 to shareholders of record at the close of business




Lilly to Participate in UBS Biopharma Conference 2023

October 26, 2023

Tags |  Financial

INDIANAPOLIS , Oct. 26, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the UBS Biopharma Conference on Nov. 8, 2023 . Patrik Jonsson, executive vice president; president, Lilly Immunology; president, Lilly USA ; and chief customer officer, will participate in a fireside chat at




Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results Announcement

October 20, 2023

Tags |  Financial

INDIANAPOLIS , Oct. 20, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2023 financial results on Thursday, Nov. 2, 2023 . Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial